<DOC>
	<DOCNO>NCT01887353</DOCNO>
	<brief_summary>The purpose study evaluate efficacy ranolazine prevention recurrent atrial fibrillation post-cardioversion patient heart failure preserve ejection fraction .</brief_summary>
	<brief_title>The Use Ranolazine Atrial Fibrillation Diastolic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Ranolazine</mesh_term>
	<criteria>Male nonpregnant female &gt; 18 year age ; Documentation heart failure NYHA class II III ; Documented history symptomatic AF &lt; 6 month duration time presentation , currently AF time external electrical cardioversion , successfully restore normal sinus rhythm ; Percutaneous coronary intervention ( PCI ) patient place anticoagulation warfarin postcardioversion ( rivaroxaban dabigatran ) ; Demonstration preserve ejection fraction ( EF ) echocardiography ; Echocardiographic evidence impair diastolic filling . Known history permanent longstanding AF ( &gt; 6 month ) ; Other acutely reversible cause AF , include limited : hyperthyroidism , pericarditis , myocarditis pulmonary embolism ; Known history cirrhosis ; NYHA Class IV ; Myocardial Infarction , unstable angina , coronary artery bypass graft surgery within three month prior screen ; Percutaneous coronary intervention ( PCI ) within 4 week prior screen , patient need place rivaroxaban dabigatran postcardioversion ; Clinically significant valvular disease ; Clinically significant pulmonary disease ; Stroke within 3 month prior screen ; Creatinine clearance &lt; 30 mL/min calculate CockcroftGault formula ; Use antiarrhythmic drug ( Class Ia IIIc ) within 3 month prior screen ; Concurrent use drug consider strong inhibitor CYP3A ; Concurrent use drug consider CYP3A inducer ; Prior treatment ranolazine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>heart failure</keyword>
	<keyword>ranolazine</keyword>
	<keyword>cardioversion</keyword>
	<keyword>persistent AF</keyword>
	<keyword>paroxysmal AF</keyword>
</DOC>